Regeneron Pharmaceuticals
REGN
REGN
920 hedge funds and large institutions have $42.3B invested in Regeneron Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 137 funds opening new positions, 379 increasing their positions, 287 reducing their positions, and 111 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $44.3B → $42.3B (-$1.94B)
1.1% less ownership
Funds ownership: 86.28% → 85.18% (-1.1%)
33% less call options, than puts
Call options by funds: $917M | Put options by funds: $1.38B
Holders
920
Holding in Top 10
17
Calls
$917M
Puts
$1.38B
Top Buyers
| 1 | +$363M | |
| 2 | +$341M | |
| 3 | +$239M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$157M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$149M |
Top Sellers
| 1 | -$968M | |
| 2 | -$397M | |
| 3 | -$360M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$258M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$236M |